An HIV Patient with Hepatic Flare after the Initiation of HBV-active Antiretroviral Therapy
A 39-year-old man presented a CD4 T cell count of 78/μL and HIV-RNA at 6.6×105 copies/mL at his first medical examination. After the 58th day, we initiated HBV-active antiretroviral therapy. Three months after the start of antiretroviral therapy, he was diagnosed with hepatic flare on the basis of e...
Saved in:
Published in | Internal Medicine Vol. 51; no. 12; pp. 1623 - 1626 |
---|---|
Main Authors | , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Japan
The Japanese Society of Internal Medicine
01.01.2012
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | A 39-year-old man presented a CD4 T cell count of 78/μL and HIV-RNA at 6.6×105 copies/mL at his first medical examination. After the 58th day, we initiated HBV-active antiretroviral therapy. Three months after the start of antiretroviral therapy, he was diagnosed with hepatic flare on the basis of elevated AST and ALT levels without detecting HBV-DNA. Although after continuing the medication his AST and ALT levels increased to 700 IU/L and 1,400 IU/L, respectively, he showed improvement following a natural course and was discharged from hospital after the 169th day. This is a case of hepatic flare likely caused by immune reconstitution associated with resolved HBV infection. |
---|---|
AbstractList | A 39-year-old man presented a CD4 T cell count of 78/ mu L and HIV-RNA at 6.6x105 copies/mL at his first medical examination. After the 58th day, we initiated HBV-active antiretroviral therapy. Three months after the start of antiretroviral therapy, he was diagnosed with hepatic flare on the basis of elevated AST and ALT levels without detecting HBV-DNA. Although after continuing the medication his AST and ALT levels increased to 700 IU/L and 1,400 IU/L, respectively, he showed improvement following a natural course and was discharged from hospital after the 169th day. This is a case of hepatic flare likely caused by immune reconstitution associated with resolved HBV infection. A 39-year-old man presented a CD4 T cell count of 78/μL and HIV-RNA at 6.6×105 copies/mL at his first medical examination. After the 58th day, we initiated HBV-active antiretroviral therapy. Three months after the start of antiretroviral therapy, he was diagnosed with hepatic flare on the basis of elevated AST and ALT levels without detecting HBV-DNA. Although after continuing the medication his AST and ALT levels increased to 700 IU/L and 1,400 IU/L, respectively, he showed improvement following a natural course and was discharged from hospital after the 169th day. This is a case of hepatic flare likely caused by immune reconstitution associated with resolved HBV infection. A 39-year-old man presented a CD4 T cell count of 78/µL and HIV-RNA at 6.6 × 10(5) copies/mL at his first medical examination. After the 58th day, we initiated HBV-active antiretroviral therapy. Three months after the start of antiretroviral therapy, he was diagnosed with hepatic flare on the basis of elevated AST and ALT levels without detecting HBV-DNA. Although after continuing the medication his AST and ALT levels increased to 700 IU/L and 1,400 IU/L, respectively, he showed improvement following a natural course and was discharged from hospital after the 169th day. This is a case of hepatic flare likely caused by immune reconstitution associated with resolved HBV infection. |
Author | Kawano, Shinji Hoshina, Tokio Tamura, Kumi Nakazawa, Yasushi Sato, Fumiya Onodera, Shoichi Hori, Seiji Kato, Tetsuro Yoshida, Masaki Yoshikawa, Koji |
Author_xml | – sequence: 1 fullname: Yoshida, Masaki organization: Department of Infectious Diseases and Infection Control, The Jikei University School of Medicine, Japan – sequence: 2 fullname: Hoshina, Tokio organization: Department of Infectious Diseases and Infection Control, The Jikei University School of Medicine, Japan – sequence: 3 fullname: Tamura, Kumi organization: Department of Infectious Diseases and Infection Control, The Jikei University School of Medicine, Japan – sequence: 4 fullname: Kawano, Shinji organization: Department of Infectious Diseases and Infection Control, The Jikei University School of Medicine, Japan – sequence: 5 fullname: Kato, Tetsuro organization: Department of Infectious Diseases and Infection Control, The Jikei University School of Medicine, Japan – sequence: 6 fullname: Sato, Fumiya organization: Department of Infectious Diseases and Infection Control, The Jikei University School of Medicine, Japan – sequence: 7 fullname: Nakazawa, Yasushi organization: Department of Infectious Diseases and Infection Control, The Jikei University School of Medicine, Japan – sequence: 8 fullname: Yoshikawa, Koji organization: Department of Infectious Diseases and Infection Control, The Jikei University School of Medicine, Japan – sequence: 9 fullname: Onodera, Shoichi organization: Department of Infectious Diseases and Infection Control, The Jikei University School of Medicine, Japan – sequence: 10 fullname: Hori, Seiji organization: Department of Infectious Diseases and Infection Control, The Jikei University School of Medicine, Japan |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/22728503$$D View this record in MEDLINE/PubMed |
BookMark | eNqFkU9rGzEQxUVIiO0kX6Ho2Ms6-re72qMbmtgQcA5pLj0ss_KoVlhrXUlO8bevjF0fSqGXGYb5zTx4b0Iu_eCREMrZVPCquXc-YfDQb3DljPM4Lfm0FkpdkDGXqilqIctLMmYN14XIZUQmMb4zJnXdiGsyEqIWumRyTL7PPJ0v3ugLJIc-0V8urekct3k09LGHgBRsFqNpjXThXXJ5M3g6WDr_8laASe4D6cwnFzCF4cMF6OnrGgNs97fkykIf8e7Ub8i3x6-vD_Piefm0eJg9F6asWCpAgjC2QqVt3XFEZTXoijVKV9xKqS0XbCWbrrMro5S1jeKlNIClYh0qVssb8vn4dxuGnzuMqd24aLDvweOwiy0XUnNe85r9H2VCiFIzJTOqj6gJQ4wBbbsNbgNhn6H2kEL7dwptydtDCvn000ll1-Xl-fCP7RlYHoH3mOAHngEI2fYe__mZi0M9SZxJs4bQope_AWc-pu4 |
CitedBy_id | crossref_primary_10_1007_s11901_014_0238_2 crossref_primary_10_1007_s40278_013_0766_5 |
Cites_doi | 10.1007/s11908-005-0068-z 10.1097/QAD.0b013e328013db9c 10.1016/j.clinre.2011.07.018 10.1097/01.aids.0000161769.06158.8a 10.1086/428502 10.1111/j.1872-034X.2007.00263.x 10.1073/pnas.120055097 10.1016/S0140-6736(02)11913-1 10.1086/597276 10.1086/377135 10.1016/S1473-3099(05)70141-9 10.1046/j.1468-1293.2000.00012.x 10.1097/01.aids.0000232232.41877.2a 10.1007/s10165-011-0521-9 10.7326/0003-4819-146-2-200701160-00003 10.1086/499356 10.1097/00002030-200012220-00011 |
ContentType | Journal Article |
Copyright | 2012 by The Japanese Society of Internal Medicine |
Copyright_xml | – notice: 2012 by The Japanese Society of Internal Medicine |
DBID | CGR CUY CVF ECM EIF NPM AAYXX CITATION 7X8 7U9 H94 |
DOI | 10.2169/internalmedicine.51.7244 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef MEDLINE - Academic Virology and AIDS Abstracts AIDS and Cancer Research Abstracts |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef MEDLINE - Academic AIDS and Cancer Research Abstracts Virology and AIDS Abstracts |
DatabaseTitleList | AIDS and Cancer Research Abstracts MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1349-7235 |
EndPage | 1626 |
ExternalDocumentID | 10_2169_internalmedicine_51_7244 22728503 article_internalmedicine_51_12_51_51_7244_article_char_en |
Genre | Journal Article Case Reports |
GroupedDBID | --- .55 29J 2WC 3O- 53G 5GY 7.U AAPBV AAUGY ACPRK ADBBV ADRAZ AENEX AFRAH ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL CS3 DIK DU5 EBS EJD EMOBN F5P HYE JSF JSH M48 M~E OK1 P2P RJT RNS RPM RZJ TKC TR2 X7M XSB CGR CUY CVF ECM EIF NPM PGMZT AAYXX CITATION 7X8 7U9 H94 |
ID | FETCH-LOGICAL-c560t-a3a2cf6e48f7b1ee4f8a86094861f338f120d39bbfdc44ff94153cae540be4073 |
ISSN | 0918-2918 |
IngestDate | Sat Jun 22 20:24:53 EDT 2024 Fri Jun 28 15:04:36 EDT 2024 Fri Aug 23 00:46:17 EDT 2024 Sat Sep 28 08:33:37 EDT 2024 Thu Aug 17 20:29:16 EDT 2023 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 12 |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c560t-a3a2cf6e48f7b1ee4f8a86094861f338f120d39bbfdc44ff94153cae540be4073 |
Notes | ObjectType-Case Study-2 SourceType-Scholarly Journals-1 ObjectType-Feature-4 content type line 23 ObjectType-Report-1 ObjectType-Article-3 ObjectType-Article-2 ObjectType-Feature-1 |
OpenAccessLink | https://www.jstage.jst.go.jp/article/internalmedicine/51/12/51_51.7244/_article/-char/en |
PMID | 22728503 |
PQID | 1022258043 |
PQPubID | 23479 |
PageCount | 4 |
ParticipantIDs | proquest_miscellaneous_1238117170 proquest_miscellaneous_1022258043 crossref_primary_10_2169_internalmedicine_51_7244 pubmed_primary_22728503 jstage_primary_article_internalmedicine_51_12_51_51_7244_article_char_en |
PublicationCentury | 2000 |
PublicationDate | 2012-01-01 |
PublicationDateYYYYMMDD | 2012-01-01 |
PublicationDate_xml | – month: 01 year: 2012 text: 2012-01-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | Japan |
PublicationPlace_xml | – name: Japan |
PublicationTitle | Internal Medicine |
PublicationTitleAlternate | Intern. Med. |
PublicationYear | 2012 |
Publisher | The Japanese Society of Internal Medicine |
Publisher_xml | – name: The Japanese Society of Internal Medicine |
References | 15. Watanabe K, Takase K, Ohno S, Ideguchi H, Nozaki A, Ishigatsubo Y. Reactivation of hepatitis B virus in a hepatitis B surface antigen-negative patient with rheumatoid arthritis treated with methotrexate. Mod Rheumatol 2011 Sep 8 [Epub ahead of print]. 1. Lohse N, Hansen AB, Pedersen G, et al. Survival of persons with and without HIV infection in Denmark, 1995-2005. Ann Intern Med 146: 87-95, 2007. 17. French MA, Lenzo N, John M, et al. Immune restoration disease after the treatment of immunodeficient HIV-infected patients with highly active antiretroviral therapy. HIV Med 1: 107-115, 2000. 18. Shelburne SA, Visnegarwala F, Darcourt J, et al. Incidence and risk factors for immune reconstitution inflammatory syndrome during highly active antiretroviral therapy. AIDS 19: 399-406, 2005. 10. Cicconi P, Cozzi-Lepri A, Phillips A, et al; ICoNA Study Group. Is the increased risk of liver enzyme elevation in patients co-infected with HIV and hepatitis virus greater in those taking antiretroviral therapy? AIDS 21: 599-606, 2007. 13. Koo YX, Tan DS, Tan IB, Tao M, Lim ST. Hepatitis B virus reactivation in a patient with resolved hepatitis B virus infection receiving maintenance rituximab for malignant B-cell lymphoma. Ann Intern Med 150: 655-656, 2009. 6. Koike K, Kikuchi Y, Kato M, et al. Prevalence of hepatitis B virus infection in Japanese patients with HIV. Hepatol Res 38: 310-314, 2008. 12. Núñez M, Soriano V. Management of patients co-infected with hepatitis B virus and HIV. Lancet Infect Dis 5: 374-382, 2005. 3. Ratnam I, Chiu C, Kandala NB, Easterbrook PJ. Incidence and risk factors for immune reconstitution inflammatory syndrome in an ethnically diverse HIV type 1-infected cohort. Clin Infect Dis 42: 418-427, 2006. 2. Murdoch DM, Venter WD, Van Rie A, Feldman C. Immune reconstitution inflammatory syndrome (IRIS): review of common infectious manifestations and treatment options. AIDS Res Ther 4: 9, 2007. 4. Thio CL, Seaberg EC, Skolasky R Jr, et al. HIV-1, hepatitis B virus, and risk of liver-related mortality in the Multicenter Cohort Study (MACS). Lancet 360: 1921-1926, 2002. 19. Lascar RM, Lopes AR, Gilson RJ, et al. Effect of HIV infection and antiretroviral therapy on hepatitis B virus (HBV)-specific T cell responses in patients who have resolved HBV infection. J Infect Dis 191: 1169-1179, 2005. 14. Papamichalis P, Alexiou A, Boulbou M, Dalekos GN, Rigopoulou EI. Reactivation of resolved hepatitis B virus infection after immunosuppression: is it time to adopt pre-emptive therapy? Clin Res Hepatol Gastroenterol 36: 84-93, 2011. 16. Kato M, Atsumi T, Kurita T, et al. Hepatitis B virus reactivation by immunosuppressive therapy in patients with autoimmune diseases: risk analysis in Hepatitis B surface antigen-negative cases. J Rheumatol 38: 2209-2214, 2011. 9. Kress KD. Antiretroviral-associated hepatotoxicity. Curr Infect Dis Rep 7: 103-107, 2005. 7. Filippini P, Coppola N, Pisapia R, et al. Impact of occult hepatitis B virus infection in HIV patients naive for antiretroviral therapy. AIDS 20: 1253-1260, 2006. 20. Crane M, Oliver B, Matthews G, et al. Immunopathogenesis of hepatic flare in HIV/hepatitis B virus (HBV)-coinfected individuals after the initiation of HBV-active antiretroviral therapy. J Infect Dis 199: 974-981, 2009. 11. Sulkowski MS, Thomas DL, Chaisson RE, Moore RD. Hepatotoxicity associated with antiretroviral therapy in adults infected with human immunodeficiency virus and the role of hepatitis C or B virus infection. JAMA 283: 74-80, 2000. 8. den Brinker M, Wit FW, Wertheim-van Dillen PM, et al. Hepatitis B and C virus co-infection and the risk for hepatotoxicity of highly active antiretroviral therapy in HIV-1 infection. AIDS 14: 2895-2902, 2000. 5. Kellerman SE, Hanson DL, McNaughten AD, Fleming PL. Prevalence of chronic hepatitis B and incidence of acute hepatitis B infection in human immunodeficiency virus-infected subjects. J Infect Dis 188: 571-577, 2003. 11 12 13 14 15 16 17 18 19 1 2 3 4 5 6 7 8 9 10 |
References_xml | – ident: 2 – ident: 9 doi: 10.1007/s11908-005-0068-z – ident: 10 doi: 10.1097/QAD.0b013e328013db9c – ident: 13 doi: 10.1016/j.clinre.2011.07.018 – ident: 17 doi: 10.1097/01.aids.0000161769.06158.8a – ident: 18 doi: 10.1086/428502 – ident: 6 doi: 10.1111/j.1872-034X.2007.00263.x – ident: 12 doi: 10.1073/pnas.120055097 – ident: 4 doi: 10.1016/S0140-6736(02)11913-1 – ident: 15 – ident: 19 doi: 10.1086/597276 – ident: 5 doi: 10.1086/377135 – ident: 11 doi: 10.1016/S1473-3099(05)70141-9 – ident: 16 doi: 10.1046/j.1468-1293.2000.00012.x – ident: 7 doi: 10.1097/01.aids.0000232232.41877.2a – ident: 14 doi: 10.1007/s10165-011-0521-9 – ident: 1 doi: 10.7326/0003-4819-146-2-200701160-00003 – ident: 3 doi: 10.1086/499356 – ident: 8 doi: 10.1097/00002030-200012220-00011 |
SSID | ssj0038792 |
Score | 1.9719204 |
Snippet | A 39-year-old man presented a CD4 T cell count of 78/μL and HIV-RNA at 6.6×105 copies/mL at his first medical examination. After the 58th day, we initiated... A 39-year-old man presented a CD4 T cell count of 78/µL and HIV-RNA at 6.6 × 10(5) copies/mL at his first medical examination. After the 58th day, we initiated... A 39-year-old man presented a CD4 T cell count of 78/ mu L and HIV-RNA at 6.6x105 copies/mL at his first medical examination. After the 58th day, we initiated... |
SourceID | proquest crossref pubmed jstage |
SourceType | Aggregation Database Index Database Publisher |
StartPage | 1623 |
SubjectTerms | Adult Alanine Transaminase - blood Anti-HIV Agents - therapeutic use antiretroviral therapy Antiviral Agents - adverse effects Aspartate Aminotransferases - blood CD4 antigen CD4 Lymphocyte Count hepatic flare Hepatitis B - complications Hepatitis B - drug therapy Hepatitis B - immunology Hepatitis B - virology Hepatitis B virus Hepatitis B virus - genetics Hepatitis B virus - isolation & purification HIV Infections - complications HIV Infections - immunology HIV Infections - virology Hospitals Human immunodeficiency virus human immunodeficiency virus (HIV) Humans Immune reconstitution immune reconstitution inflammatory syndrome (IRIS) Immune Reconstitution Inflammatory Syndrome - etiology Immune Reconstitution Inflammatory Syndrome - immunology Immune Reconstitution Inflammatory Syndrome - virology Infection Liver Lymphocytes T Male resolved hepatitis B virus RNA, Viral - blood Viral Load |
Title | An HIV Patient with Hepatic Flare after the Initiation of HBV-active Antiretroviral Therapy |
URI | https://www.jstage.jst.go.jp/article/internalmedicine/51/12/51_51.7244/_article/-char/en https://www.ncbi.nlm.nih.gov/pubmed/22728503 https://search.proquest.com/docview/1022258043 https://search.proquest.com/docview/1238117170 |
Volume | 51 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
ispartofPNX | Internal Medicine, 2012, Vol.51(12), pp.1623-1626 |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lj9MwELbKgtBeEG-6PGQkblVK_EjiHAsCFVbLhS5axCGyU3u3habVNhWPX8_4kTS72iLgErWxHSczn8fj8cwYoRcpT4SMZRmVRPKIKx5HMknhbxITHYupUNLaO44-pONj_v4kOen1fnS8lja1Gpa_rowr-R-uwj3gq42S_QfOtg-FG_Ab-AtX4DBc_4rHo2owhuVbyI3qbapneuWSsJpv1qfLHwFulcuZ9RJq9cPxq0-RdKJuAKQFsVdb04IN1q87aQbmWzd3p7U2G_FWLZ0sv_50ZlbrWdqxJ3xers9mU-njgNagn7bAsQU-Ag3aevcvbzNYbM59YNpm0dY-lN-lOxV88BFazWdd64Rz82isE9pLVMbzKKM-J0kjckOO2QAt2hGgJPXhx5clOyWpTYw6Cx_cfO8wIcOM-gySHYavFo7jlGZUJDHbznWtB2JTdA1dpyCi3Ab_u8NmDmciy4Pfl-345a5ubSrp8KALes2NOaj2p3r3qsVpL5Pb6FZYduCRx9Ad1NPVXXTzKHR0D30ZVRighAOUsIUSDlDCDkrYQQkDPPAWSnhp8BZK-CKUcIDSfXT89s3k9TgK527ACE3jOpJM0tKkmguTKaI1N0KKNM65SIlhTBhC4ynLlTLTknNjclACWSk1KP9Kc5gzHqC9alnpRwjH0lAltc6ngvGSESVKo6CB0DLNc532EWmoVqx8epUClqWW6MVlohcJKSzR-2jsydu2CAPwyhaE2mto2ta0IY0gQfroecOgAsSq3SuTlV5u1oU3hIiYsz_UseouyUgW99FDz932lRpYHOwseYz2twPmCdqrzzf6KSi4tXrmsPgbVWyrhg |
link.rule.ids | 315,783,787,27936,27937 |
linkProvider | Flying Publisher |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=An+HIV+patient+with+hepatic+flare+after+the+initiation+of+HBV-active+antiretroviral+therapy&rft.jtitle=Internal+medicine+%28Tokyo%2C+1992%29&rft.au=Yoshida%2C+Masaki&rft.au=Hoshina%2C+Tokio&rft.au=Tamura%2C+Kumi&rft.au=Kawano%2C+Shinji&rft.date=2012-01-01&rft.eissn=1349-7235&rft.volume=51&rft.issue=12&rft.spage=1623&rft_id=info:doi/10.2169%2Finternalmedicine.51.7244&rft_id=info%3Apmid%2F22728503&rft.externalDocID=22728503 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0918-2918&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0918-2918&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0918-2918&client=summon |